Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 497833-27-9
2. Itf2357
3. Givinostat [inn]
4. Givinostat Free Base
5. Itf-2357
6. [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate
7. 5p60f84fbh
8. Chembl1213492
9. 497833-27-9 (free Base)
10. (6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate
11. (6-((diethylamino)methyl)naphthalen-2-yl)methyl(4-(hydroxycarbamoyl)phenyl)carbamate
12. [4-[(hydroxyamino)carbonyl]phenyl]carbamic Acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl Ester
13. Gavinostat
14. 4-[(hydroxyamino)carbonyl]phenyl]carbamic Acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl Ester
15. Unii-5p60f84fbh
16. {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate
17. Gavinostat;itf-2357
18. Gtpl7490
19. Schembl1555814
20. Chebi:94187
21. Dtxsid70198049
22. Bcp29856
23. Zinc3820616
24. Bdbm50105329
25. Cs-4727
26. Db12645
27. Ex-5958
28. [6-(diethylaminomethyl)-2-naphthyl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate
29. Ac-31380
30. Bcb04_000011
31. Hy-14842
32. Ec-000.2471
33. 833h279
34. A923985
35. Q426257
36. Gavinostat; Itf-2357; Itf2357; Itf 2357
37. Brd-k13810148-001-01-3
38. Carbamic Acid, (4-((hydroxyamino)carbonyl)phenyl)-, (6-((diethylamino)methyl)-2-naphthalenyl)methyl Ester
39. Qcm
Molecular Weight | 421.5 g/mol |
---|---|
Molecular Formula | C24H27N3O4 |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 9 |
Exact Mass | 421.20015635 g/mol |
Monoisotopic Mass | 421.20015635 g/mol |
Topological Polar Surface Area | 90.9 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 575 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Juvenile idiopathic arthritis
Market Place
ABOUT THIS PAGE
55
PharmaCompass offers a list of Givinostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Givinostat manufacturer or Givinostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Givinostat manufacturer or Givinostat supplier.
PharmaCompass also assists you with knowing the Givinostat API Price utilized in the formulation of products. Givinostat API Price is not always fixed or binding as the Givinostat Price is obtained through a variety of data sources. The Givinostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Givinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Givinostat, including repackagers and relabelers. The FDA regulates Givinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Givinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Givinostat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Givinostat supplier is an individual or a company that provides Givinostat active pharmaceutical ingredient (API) or Givinostat finished formulations upon request. The Givinostat suppliers may include Givinostat API manufacturers, exporters, distributors and traders.
click here to find a list of Givinostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Givinostat DMF (Drug Master File) is a document detailing the whole manufacturing process of Givinostat active pharmaceutical ingredient (API) in detail. Different forms of Givinostat DMFs exist exist since differing nations have different regulations, such as Givinostat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Givinostat DMF submitted to regulatory agencies in the US is known as a USDMF. Givinostat USDMF includes data on Givinostat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Givinostat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Givinostat suppliers with USDMF on PharmaCompass.
Givinostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Givinostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Givinostat GMP manufacturer or Givinostat GMP API supplier for your needs.
A Givinostat CoA (Certificate of Analysis) is a formal document that attests to Givinostat's compliance with Givinostat specifications and serves as a tool for batch-level quality control.
Givinostat CoA mostly includes findings from lab analyses of a specific batch. For each Givinostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Givinostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Givinostat EP), Givinostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Givinostat USP).